SD Biosensor, Inc. (KRX:137310)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,060.00
-130.00 (-2.10%)
Last updated: Sep 2, 2026, 11:00 AM KST

SD Biosensor Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-729,491-512,106-98,411-467,712911,3621,088,471
Depreciation & Amortization
125,725134,266141,694137,54140,82019,115
Loss (Gain) From Sale of Assets
2,291-7,748-4,0921,0451,8041,373
Asset Writedown & Restructuring Costs
753,790753,790135,26299,8698,6342,283
Loss (Gain) From Sale of Investments
-13,693-530.9412,378-4,046-3,107-9,480
Loss (Gain) on Equity Investments
15,52015,1553,532986.912,560-2,802
Stock-Based Compensation
11,546803.15905.39969.115,55918,867
Provision & Write-off of Bad Debts
-406.34-923.756,9764,0579,6401,319
Other Operating Activities
-51,92722,884-24,055-33,212-31,661224,801
Change in Accounts Receivable
-23,661-29,3709,636-5,17762,516185,970
Change in Inventory
-6,235-10,303-5,89681,644-28,60435,418
Change in Accounts Payable
9,60119,6358,069-31,006-36,683-304,205
Change in Other Net Operating Assets
-36,316-28,037-29,472-27,277-63,831-26,185
Operating Cash Flow
56,743357,516156,527-242,319889,0081,234,945
Operating Cash Flow Growth
-86.35%128.41%---28.01%149.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-45,614-57,086-78,783-142,566-301,999-190,053
Sale of Property, Plant & Equipment
6,80986,3819,5682,9622,915731.12
Cash Acquisitions
218.45-8,066--1,748,595-47,154-36,764
Divestitures
--565.25---
Sale (Purchase) of Intangibles
277.43-403.73-2,118-1,864-3,248-1,980
Investment in Securities
405,762-155,268-260,670-16,366706,574-901,853
Other Investing Activities
-25,958860.71-7,649-6,1002,658169,690
Investing Cash Flow
334,538-139,944-338,926-1,912,529359,745-960,569

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,059--81,679-
Long-Term Debt Issued
-14,93313,640835,483--
Total Debt Issued
4,30517,99313,640835,48381,679-
Short-Term Debt Repaid
--1,940-133,468-255,617-81,695-1,765
Long-Term Debt Repaid
--8,042-8,041-13,822-11,623-4,968
Total Debt Repaid
-421,903-9,982-141,509-269,439-93,319-6,733
Net Debt Issued (Repaid)
-417,5988,011-127,869566,044-11,640-6,733
Issuance of Common Stock
-164.82-227,6042,383507,472
Repurchase of Common Stock
-0-11,575-18,425---99,644
Dividends Paid
-23,964-24,183-38.07-29,550-198,735-49,831
Other Financing Activities
-1,719067.35,664-17,7452,839
Financing Cash Flow
-443,281-27,582-146,266769,762-225,737354,102

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
8,575-633.5623,705-5,476-31,6659,899
Net Cash Flow
-43,425189,356-304,960-1,390,561991,351638,377

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
11,129300,43177,744-384,884587,0081,044,892
Free Cash Flow Growth
-96.77%286.44%---43.82%137.22%
Free Cash Flow Margin
1.51%42.28%11.19%-58.70%20.02%35.66%
Free Cash Flow Per Share
92.972510.42635.94-3471.825794.8110714.52
Levered Free Cash Flow
-34,969-44,627-93,587-250,134402,401766,104
Unlevered Free Cash Flow
21,64023,014-50,719-219,366403,022766,410

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
26,18425,68431,85559,592984.72497.84
Cash Income Tax Paid
601.86-338,038-84,493198,926537,064132,849
Change in Working Capital
-56,612-48,074-17,66218,183-66,603-109,001